Ester Solter
Overview
Explore the profile of Ester Solter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Temkin E, Bechor M, Lurie-Weinberger M, Keren-Paz A, Chen D, Lugassy C, et al.
Emerg Infect Dis
. 2024 Dec;
31(1):66-74.
PMID: 39714269
Escherichia coli producing OXA-48-like carbapenemases (OXA-EC) is considered a high-risk pathogen spread primarily in the community in low- and middle-income countries and nosocomially in high-income countries. We investigated the emergence...
2.
Temkin E, Solter E, Lugassy C, Chen D, Cohen A, Schwaber M, et al.
Clin Infect Dis
. 2024 Mar;
79(1):22-29.
PMID: 38447961
Background: Little is known about the risk of progression from carbapenemase-producing Enterobacterales (CPE) carriage to CPE bloodstream infection (BSI) outside of high-risk settings. We aimed to determine the incidence of...
3.
Ben-David D, Vaturi A, Wulffhart L, Temkin E, Solter E, Carmeli Y, et al.
Euro Surveill
. 2023 Jun;
28(25).
PMID: 37347415
BackgroundCentral line-associated bloodstream infection (CLABSI) is among the most common preventable infectious complications in patients in intensive care units (ICU). In 2011, the Israel National Center for Infection Control initiated...
4.
Dickstein Y, Solter E, Schwartz D, Nutman A, Harevrich I, Wulffhart L, et al.
Clin Microbiol Infect
. 2021 Jun;
27(10):1518.e1-1518.e3.
PMID: 34111587
Objectives: The Israeli national policy for containing carbapenemase-producing Enterobacterales (CPE) includes a protocol allowing for discontinuation of carrier status following spontaneous decolonization. We examined the strategy's effectiveness based on carbapenemase...
5.
Ben-David D, Vaturi A, Solter E, Rubinovitch B, Lellouche J, Schwartz D, et al.
Infect Control Hosp Epidemiol
. 2021 May;
43(6):742-746.
PMID: 34011423
Background: In June 2018, the Ministry of Health received notification from 2 hospitals about 2 patients who presented with overwhelming sepsis that developed within 24 hours after a dental procedure....
6.
Solter E, Kwong J, Walton A, Sherry N, Howden B, Grayson M, et al.
Infect Control Hosp Epidemiol
. 2020 Dec;
42(9):1124-1127.
PMID: 33371910
We characterized 57 isolates from a 2-phase clonal outbreak of New Delhi metallo-β-lactamase-producing Eschericha coli, involving 9 Israeli hospitals; all but 1 isolate belonged to sequence-type (ST) 410. Most isolates...
7.
Frenk S, Rakovitsky N, Temkin E, Schechner V, Cohen R, Kloyzner B, et al.
Antibiotics (Basel)
. 2020 Oct;
9(10).
PMID: 33081087
Infections caused by extended-spectrum beta-lactamase-producing (ESBL-KP) are on a constant rise and are a noted cause of outbreaks in neonatal intensive care units (NICUs). We used whole genome sequencing (WGS)...
8.
Rakovitsky N, Frenk S, Kon H, Schwartz D, Temkin E, Solter E, et al.
J Clin Microbiol
. 2020 Mar;
58(5).
PMID: 32161093
The IR Biotyper is a new automated typing system based on Fourier-transform infrared (FT-IR) spectroscopy that gives results within 4 h. We aimed (i) to use the IR Biotyper to...
9.
Ben-David D, Masarwa S, Fallach N, Temkin E, Solter E, Carmeli Y, et al.
Clin Infect Dis
. 2020 Feb;
72(5):829-835.
PMID: 32034414
Background: In 2009, the Israeli Ministry of Health implemented in post-acute care hospitals (PACHs) a process of discontinuing carbapenem-resistant Enterobacteriaceae (CRE) carrier status. We evaluated the policy's impact on isolation-days,...
10.
Schwaber M, Vaturi A, Rubinovitch B, Ben-David D, Solter E, Carmeli Y
Isr Med Assoc J
. 2019 Sep;
21(8):568-569.
PMID: 31529942
No abstract available.